31 10, 2018 M Kursat Evrenos et. al, Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population Diatech Pharmacogenetics2018-12-04T14:23:43+01:00 Leggi di più
20 08, 2018 Irene Baldi et. al, Rosai-Dorfman Disease Presenting As Peripheral Vascular Insufficiency Diatech Pharmacogenetics2018-08-27T14:13:58+02:00 Leggi di più
6 04, 2018 Valeria Maffeis et. al, Onycholemmal carcinoma: A case report with its molecular profiling Diatech Pharmacogenetics2018-04-12T15:41:02+02:00 Leggi di più
26 03, 2018 Roberta Minari et. al, Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR-mutated patient. Diatech Pharmacogenetics2018-04-12T14:59:43+02:00 Leggi di più
12 01, 2018 Elena Bonaparte et. al, Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry Diatech Pharmacogenetics2018-03-08T13:45:37+01:00 Leggi di più
27 12, 2017 Thibaut Kritter et. al, Radiomic Biomarkers Helps to Better Predict Progression Free Survival of Gliomas Diatech Pharmacogenetics2018-03-08T13:56:50+01:00 Leggi di più
18 09, 2017 Graziella Pinotti et al.,1335PEGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations Diatech Pharmacogenetics2017-10-02T14:48:56+02:00 Leggi di più
24 08, 2017 Annamaria Ruzzo et al., Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer Diatech Pharmacogenetics2017-08-28T16:02:44+02:00 Leggi di più
30 03, 2017 Deborah Saraggi et al., Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver. Pathology – Research and Practice Diatech Admin2017-08-03T15:41:48+02:00 Leggi di più
7 07, 2016 Rossella Bruno et al., Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction. Molecular Medicine Reports Diatech Pharmacogenetics2017-08-07T12:16:44+02:00 Leggi di più
